Emergent Biosolutions, Inc. EBS
$7.41
+2.63%
at last close
Financials (TTM)
- Revenue
- $676.80 million
- Net Income
- $-8,600,000
- Net Margin
- -1.27%
- Return on Equity
- -1.64%
- Debt-to-Equity
- 1.13
- P/E Ratio
- —
- Price / Book
- 0.71
- Price / Sales
- 0.55
Over the trailing twelve months, Emergent Biosolutions, Inc. generated revenue of $676.80 million and net income of $-8,600,000, a net margin of -1.27%.
At the last closing price of $7.41, EBS trades at 0.55 times sales, with a market capitalization of $372.53 million.
Key Stats
- Last Close
- $7.41
- Market Cap
- $372.53 million
- 52-Week Range
- $5.62 – $14.06
- Average Volume
- 764K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.